Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32+0.00 (+1.30%)
Close on Nov 18, 2026Market cap $11.66MP/E –Yield –
Dyadic International operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Dyadic International's operating income for the twelve months ending Sep 30, 2026 was -$7.31M. For fiscal 2025 it was -$7.19M. The highest annual figure on record is -$5.90M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.19M | – |
| FY2024 | Dec 31, 2024 | -$5.90M | – |
| FY2023 | Dec 31, 2023 | -$8.23M | – |
| FY2022 | Dec 31, 2022 | -$10.17M | – |
| FY2021 | Dec 31, 2021 | -$14.73M | – |
| FY2020 | Dec 31, 2020 | -$10.03M | – |
| FY2019 | Dec 31, 2019 | -$9.28M | – |
| FY2018 | Dec 31, 2018 | -$7.59M | – |
| FY2017 | Dec 31, 2017 | -$7.13M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.81M | – |
| Q2 FY2026 | Jun 30, 2026 | -$2.05M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.54M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.93M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$202.61K | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.04M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.13M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.17M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.72M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.29M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.24M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.86M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.32M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.32M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.87M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.32B | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.80M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.38M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.94M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.94M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.96M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.44M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.78M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.82M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.23M | – |
See a number that looks wrong?